T 0055/24 of 05.02.2026
- European Case Law Identifier
- ECLI:EP:BA:2026:T005524.20260205
- Date of decision
- 5 February 2026
- Case number
- T 0055/24
- Online on
- 30 April 2026
- Petition for review of
- -
- Application number
- 15771276.1
- IPC class
- A61K 31/423C07D 263/57A61P 25/00
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- CRYSTALLINE SOLID FORMS OF 6-CARBOXY-2-(3,5-DICHLOROPHENYL)-BENZOXAZOLE
- Applicant name
- Pfizer Inc.
- Opponent name
- Alfred E. Tiefenbacher (GmbH & Co. KG)
Química Sintética, S.A.
Galenicum Health S.L.U.
Hollatz, Christian
KELTIE LLP - Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(2)
- Keywords
- Basis of decision - text or agreement to text withdrawn by patent proprietor
Basis of decision - patent revoked - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.